Cargando…
The Vitamin Nicotinamide: Translating Nutrition into Clinical Care
Nicotinamide, the amide form of vitamin B(3 )(niacin), is changed to its mononucleotide compound with the enzyme nicotinic acide/nicotinamide adenylyl-transferase, and participates in the cellular energy metabolism that directly impacts normal physiology. However, nicotinamide also influences oxidat...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2756609/ https://www.ncbi.nlm.nih.gov/pubmed/19783937 http://dx.doi.org/10.3390/molecules14093446 |
_version_ | 1782172503886528512 |
---|---|
author | Maiese, Kenneth Chong, Zhao Zhong Hou, Jinling Shang, Yan Chen |
author_facet | Maiese, Kenneth Chong, Zhao Zhong Hou, Jinling Shang, Yan Chen |
author_sort | Maiese, Kenneth |
collection | PubMed |
description | Nicotinamide, the amide form of vitamin B(3 )(niacin), is changed to its mononucleotide compound with the enzyme nicotinic acide/nicotinamide adenylyl-transferase, and participates in the cellular energy metabolism that directly impacts normal physiology. However, nicotinamide also influences oxidative stress and modulates multiple pathways tied to both cellular survival and death. During disorders that include immune system dysfunction, diabetes, and aging-related diseases, nicotinamide is a robust cytoprotectant that blocks cellular inflammatory cell activation, early apoptotic phosphatidylserine exposure, and late nuclear DNA degradation. Nicotinamide relies upon unique cellular pathways that involve forkhead transcription factors, sirtuins, protein kinase B (Akt), Bad, caspases, and poly (ADP-ribose) polymerase that may offer a fine line with determining cellular longevity, cell survival, and unwanted cancer progression. If one is cognizant of the these considerations, it becomes evident that nicotinamide holds great potential for multiple disease entities, but the development of new therapeutic strategies rests heavily upon the elucidation of the novel cellular pathways that nicotinamide closely governs. |
format | Text |
id | pubmed-2756609 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Molecular Diversity Preservation International |
record_format | MEDLINE/PubMed |
spelling | pubmed-27566092009-10-05 The Vitamin Nicotinamide: Translating Nutrition into Clinical Care Maiese, Kenneth Chong, Zhao Zhong Hou, Jinling Shang, Yan Chen Molecules Review Nicotinamide, the amide form of vitamin B(3 )(niacin), is changed to its mononucleotide compound with the enzyme nicotinic acide/nicotinamide adenylyl-transferase, and participates in the cellular energy metabolism that directly impacts normal physiology. However, nicotinamide also influences oxidative stress and modulates multiple pathways tied to both cellular survival and death. During disorders that include immune system dysfunction, diabetes, and aging-related diseases, nicotinamide is a robust cytoprotectant that blocks cellular inflammatory cell activation, early apoptotic phosphatidylserine exposure, and late nuclear DNA degradation. Nicotinamide relies upon unique cellular pathways that involve forkhead transcription factors, sirtuins, protein kinase B (Akt), Bad, caspases, and poly (ADP-ribose) polymerase that may offer a fine line with determining cellular longevity, cell survival, and unwanted cancer progression. If one is cognizant of the these considerations, it becomes evident that nicotinamide holds great potential for multiple disease entities, but the development of new therapeutic strategies rests heavily upon the elucidation of the novel cellular pathways that nicotinamide closely governs. Molecular Diversity Preservation International 2009-09-09 /pmc/articles/PMC2756609/ /pubmed/19783937 http://dx.doi.org/10.3390/molecules14093446 Text en © 2009 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Review Maiese, Kenneth Chong, Zhao Zhong Hou, Jinling Shang, Yan Chen The Vitamin Nicotinamide: Translating Nutrition into Clinical Care |
title | The Vitamin Nicotinamide: Translating Nutrition into Clinical Care |
title_full | The Vitamin Nicotinamide: Translating Nutrition into Clinical Care |
title_fullStr | The Vitamin Nicotinamide: Translating Nutrition into Clinical Care |
title_full_unstemmed | The Vitamin Nicotinamide: Translating Nutrition into Clinical Care |
title_short | The Vitamin Nicotinamide: Translating Nutrition into Clinical Care |
title_sort | vitamin nicotinamide: translating nutrition into clinical care |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2756609/ https://www.ncbi.nlm.nih.gov/pubmed/19783937 http://dx.doi.org/10.3390/molecules14093446 |
work_keys_str_mv | AT maiesekenneth thevitaminnicotinamidetranslatingnutritionintoclinicalcare AT chongzhaozhong thevitaminnicotinamidetranslatingnutritionintoclinicalcare AT houjinling thevitaminnicotinamidetranslatingnutritionintoclinicalcare AT shangyanchen thevitaminnicotinamidetranslatingnutritionintoclinicalcare AT maiesekenneth vitaminnicotinamidetranslatingnutritionintoclinicalcare AT chongzhaozhong vitaminnicotinamidetranslatingnutritionintoclinicalcare AT houjinling vitaminnicotinamidetranslatingnutritionintoclinicalcare AT shangyanchen vitaminnicotinamidetranslatingnutritionintoclinicalcare |